Gagner M, Pomp A, Heniford B T, Pharand D, Lacroix A
Department of General Surgery, The Cleveland Clinic Foundation, Ohio 44195, USA.
Ann Surg. 1997 Sep;226(3):238-46; discussion 246-7. doi: 10.1097/00000658-199709000-00003.
One hundred consecutive laparoscopic adrenal procedures for a variety of endocrine disorders were reviewed. There was no mortality, morbidity was 12%, and conversions was 3%. During follow-up, none had recurrence of hormonal excess. Laparoscopic adrenalectomy is the procedure of choice for adrenal removal except in carcinoma or masses > 15 cm.
The authors evaluate the effectiveness of laparoscopic adrenalectomy for a variety of endocrine disorders.
Since the first laparoscopic adrenalectomy was performed in 1992, this approach quickly has been adopted, and increasing numbers are being reported. However, the follow-up period has been too short to evaluate the completeness of these operations.
One hundred consecutive laparoscopic adrenal procedures from January 1992 until November 1996 were reviewed and followed for adequacy of resection.
Eighty-eight patients underwent 97 adrenalectomies and biopsies. The mean age was 46 years (range, 17-84 years). Indications were pheochromocytomas (n = 25), aldosterone-producing adenomas (n = 21), nonfunctional adenomas (n = 20), cortisol-producing adenomas (n = 13), Cushing's disease (n = 8), and others (n = 13). Fifty-five patients had previous abdominal surgery. Mean operative time was 123 minutes (range, 80-360 minutes), and estimated blood loss was 70 mL (range, 20-1300 mL). There was no mortality, and morbidity was encountered in 12% of patients, including three patients in whom venous thrombosis developed with two sustaining pulmonary emboli. During pheochromocytoma removal, hypertension occurred in 56% of patients and hypotension in 52%. There were three conversions to open surgery. The average length of stay has decreased from 3 days (range, 2-19 days) in the first 3 years to 2.4 days (range, 1-6 days) over the past 16 months. During follow-up (range, 1-44 months), two patients had renovascular hypertension and none had recurrence of hormonal excess.
Laparoscopic adrenalectomy is safe, effective, and decreases hospital stay and wound complications. Prior abdominal surgery is not a contraindication. Pheochromocytomas can be resected safely laparoscopically despite blood pressure variations. Venous thrombosis prophylaxis is mandatory. The laparoscopic approach is the procedure of choice for adrenalectomy except in the case of invasive carcinoma or masses > 15 cm.
回顾了连续100例因各种内分泌疾病而进行的腹腔镜肾上腺手术。无死亡病例,发病率为12%,中转开腹率为3%。在随访期间,无激素分泌过多复发情况。除了肾上腺皮质癌或肿块直径大于15 cm外,腹腔镜肾上腺切除术是肾上腺切除的首选术式。
作者评估腹腔镜肾上腺切除术治疗各种内分泌疾病的有效性。
自1992年首次进行腹腔镜肾上腺切除术以来,这种手术方式迅速被采用,且报道的病例数不断增加。然而,随访期太短,无法评估这些手术的彻底性。
回顾了1992年1月至1996年11月连续100例腹腔镜肾上腺手术,并对切除的充分性进行随访。
88例患者接受了97次肾上腺切除术和活检。平均年龄为46岁(范围17 - 84岁)。手术指征包括嗜铬细胞瘤(n = 25)、醛固酮瘤(n = 21)、无功能腺瘤(n = 20)、皮质醇瘤(n = 13)、库欣病(n = 8)以及其他疾病(n = 13)。55例患者既往有腹部手术史。平均手术时间为123分钟(范围80 - 360分钟),估计失血量为70毫升(范围20 - 1300毫升)。无死亡病例,12%的患者出现并发症,包括3例发生静脉血栓形成,其中2例发生肺栓塞。在切除嗜铬细胞瘤过程中,56%的患者出现高血压,52%的患者出现低血压。有3例中转开腹手术。平均住院时间从前3年的3天(范围2 - 19天)降至过去16个月的2.4天(范围1 - 6天)。在随访期间(范围1 - 44个月),2例患者出现肾血管性高血压,无激素分泌过多复发情况。
腹腔镜肾上腺切除术安全、有效,可缩短住院时间并减少伤口并发症。既往腹部手术并非禁忌证。尽管血压有波动,嗜铬细胞瘤仍可通过腹腔镜安全切除。必须进行静脉血栓预防。除了侵袭性肾上腺皮质癌或肿块直径大于15 cm的情况外,腹腔镜手术是肾上腺切除术的首选术式。